Franklin India Technology Fund-Growth vs Nippon India Pharma Fund-Growth Plan-Growth Option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Franklin India Technology Fund-Growth appears stronger in terms of star rating with a 5-star rating compared to Nippon India Pharma Fund-Growth Plan-Growth Option's 2-star rating, indicating a higher level of investor confidence. However, while Franklin India Technology Fund has a lower expense ratio of 1.16%, it has underperformed in returns over the 1Y, 3Y, and 5Y periods compared to Nippon India Pharma Fund, which shows significantly higher returns, especially in the 3Y CAGR at 18.96% and 5Y CAGR at 14.59%. Therefore, investors should weigh the higher returns and larger AUM of Nippon India Pharma Fund against its lower rating and slightly lower expense ratio. In summary, if an investor prioritizes returns over ratings, Nippon India Pharma Fund may be the more appealing option.
Franklin India Technology Fund-Growth
Franklin Templeton Mutual Fund
★★★★★
Equity · Sectoral
Nippon India Pharma Fund-Growth Plan-Growth Option
Nippon India Mutual Fund
★★★★★
Equity · Sectoral
| Metric | Franklin India Technol... | Nippon India Pharma Fu... |
|---|---|---|
| NAV | ₹544.36 | ₹646.81 |
| Star Rating | ★★★★★ | ★★ |
| Expense Ratio | 1.16% | 0.99% |
| AUM | ₹1,742 Cr | ₹9,166 Cr |
| 1M Return | +5.45% | +3.04% |
| 3M Return | -0.29% | +0.74% |
| 6M Return | +13.03% | +7.9% |
| 1Y Return | -5.8% | +10.92% |
| 3Y CAGR | +10.29% | +18.96% |
| 5Y CAGR | +7.22% | +14.59% |
| Risk Level | — | — |
| Fund Manager | Anand Radhakrishnan, Srikesh Nair, Varun Sharma | Sailesh Raj Bhan |